| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 129, 86-91, Copyright © 1987 by American Society for Investigative Pathology
REGULAR ARTICLES |
LM Weiss, JG Strickler, RA Warnke, DT Purtilo and J Sklar
Department of Pathology, Stanford University, California 94305.
Tissue specimens from 21 cases of Hodgkin's disease were examined for the presence of Epstein-Barr virus (EBV) and cytomegalovirus DNA by molecular hybridization techniques. EBV DNA was detected in 4 cases, including 2 of 8 cases which had been previously shown to contain clonal immunoglobulin gene rearrangements. Two of the cases containing EBV DNA were of the nodular sclerosing type and had received prior therapy; the other 2 were classified as mixed cellularity Hodgkin's disease and had not received therapy before the biopsy tissue was obtained. Analyses of the terminal portions of EBV genomes indicated a monoclonal or oligoclonal proliferation of EBV-infected cells in the tissues studied. In contrast, none of the 21 cases had detectable cytomegalovirus DNA sequences. The identification of EBV DNA may reflect the proliferation of lymphoblastoid cells due to the reduced immune competence frequently noted in Hodgkin's disease or may indicate the presence of EBV genomes within Reed-Sternberg cells.
This article has been cited by other articles:
 |
|
 |
|
  I. Guasparri, D. Bubman, and E. Cesarman EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression Blood, April 1, 2008; 111(7): 3813 - 3820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Kapatai and P Murray Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma J. Clin. Pathol., December 1, 2007; 60(12): 1342 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Perrine, O. Hermine, T. Small, F. Suarez, R. O'Reilly, F. Boulad, J. Fingeroth, M. Askin, A. Levy, S. J. Mentzer, et al. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies Blood, March 15, 2007; 109(6): 2571 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Williams and D. H. Crawford Epstein-Barr virus: the impact of scientific advances on clinical practice Blood, February 1, 2006; 107(3): 862 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. El-Guindy and G. Miller Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta J. Virol., July 15, 2004; 78(14): 7634 - 7644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Marshall, L. E. Christie, L. R. Munro, D. J. Culligan, P. W. Johnston, R. N. Barker, and M. A. Vickers Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood, March 1, 2004; 103(5): 1755 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Higa, T Kinjo, K Kamiyama, T Iwamasa, T Hamada, and K Iyama Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan J. Clin. Pathol., June 1, 2002; 55(6): 414 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Faumont, T. Al Saati, P. Brousset, C. Offer, G. Delsol, and F. Meggetto Demonstration by single-cell PCR that Reed-Sternberg cells and bystander B lymphocytes are infected by different Epstein-Barr virus strains in Hodgkin's disease J. Gen. Virol., May 1, 2001; 82(5): 1169 - 1174. [Abstract] [Full Text]
|
|
|
|
 |
|
 K J Flavell and P G Murray Hodgkin's disease and the Epstein-Barr virus Mol. Pathol., October 1, 2000; 53(5): 262 - 269. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Hjalgrim, J. Askling, P. Sorensen, M. Madsen, N. Rosdahl, H. H. Storm, S. Hamilton-Dutoit, L. S. Eriksen, M. Frisch, A. Ekbom, et al. Risk of Hodgkin's Disease and Other Cancers After Infectious Mononucleosis J Natl Cancer Inst, September 20, 2000; 92(18): 1522 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Dukers, P. Meij, M. B. H. J. Vervoort, W. Vos, R. J. Scheper, C. J. L. M. Meijer, E. Bloemena, and J. M. Middeldorp Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1 J. Immunol., July 15, 2000; 165(2): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Engel, M F Essop, P Close, P Hartley, G Pallesen, and C Sinclair-Smith Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases J. Clin. Pathol., March 1, 2000; 53(3): 182 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Ambinder Gammaherpesviruses and ""Hit-and-Run"" Oncogenesis Am. J. Pathol., January 1, 2000; 156(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Franchini, R. F. Ambinder, and M. Barry Viral Disease in Hematology Hematology, January 1, 2000; 2000(1): 409 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. MacKenzie, D. Gray, R. Pinto-Paes, L. F. M. Barrezueta, A. A. Armstrong, F. A. Alexander, D. J. McGeoch, and R. F. Jarrett Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom J. Gen. Virol., October 1, 1999; 80(10): 2741 - 2745. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Murray, L. J. Billingham, H. T. Hassan, J. R. Flavell, P. N. Nelson, K. Scott, G. Reynolds, C. M. Constandinou, D. J. Kerr, E. C. Devey, et al. Effect of Epstein-Barr Virus Infection on Response to Chemotherapy and Survival in Hodgkin's Disease Blood, July 15, 1999; 94(2): 442 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Chang, Y.-Y. Chen, W.-G. Chen, K. Hayashi, C. Bacchi, M. Bacchi, and L. M. Weiss EBNA-1 Gene Sequences in Brazilian and American Patients With Hodgkin's Disease Blood, July 1, 1999; 94(1): 244 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Murray, C. M. Constandinou, J. Crocker, L. S. Young, and R. F. Ambinder Analysis of Major Histocompatibility Complex Class I, TAP Expression, and LMP2 Epitope Sequence in Epstein-Barr Virus-Positive Hodgkin's Disease Blood, October 1, 1998; 92(7): 2477 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gaidano, A. Carbone, C. Pastore, D. Capello, A. Migliazza, A. Gloghini, S. Roncella, M. Ferrarini, G. Saglio, and R. Dalla-Favera Frequent Mutation of the 5' Noncoding Region of the BCL-6 Gene in Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphomas Blood, May 15, 1997; 89(10): 3755 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Sing, R. F. Ambinder, D. J. Hong, M. Jensen, W. Batten, E. Petersdorf, and P. D. Greenberg Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease Blood, March 15, 1997; 89(6): 1978 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dolcetti, P. Zancai, V. De Re, A. Gloghini, B. Bigoni, B. Pivetta, S. De Vita, A. Carbone, and M. Boiocchi Epstein-Barr Virus Strains With Latent Membrane Protein-1 Deletions: Prevalence in the Italian Population and High Association With Human Immunodeficiency Virus-Related Hodgkin's Disease Blood, March 1, 1997; 89(5): 1723 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.J. Oudejans, N.M. Jiwa, J.A. Kummer, G.J. Ossenkoppele, P. van Heerde, J.W. Baars, Ph.M. Kluin, J.C. Kluin-Nelemans, P.J. van Diest, J.M. Middeldorp, et al. Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease Blood, February 15, 1997; 89(4): 1376 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hummel, K. Ziemann, H. Lammert, S. Pileri, E. Sabattini, and H. Stein Hodgkin's Disease with Monoclonal and Polyclonal Populations of Reed-Sternberg Cells N. Engl. J. Med., October 5, 1995; 333(14): 901 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lieberman and R. J. Buchsbaum Using T Cells to Treat B-Cell Cancers N. Engl. J. Med., April 28, 1994; 330(17): 1231 - 1233. [Full Text]
|
|
|
|
 |
|
 H zur Hausen Viruses in human cancers Science, November 22, 1991; 254(5035): 1167 - 1173. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
